Studies show NOVOS’ ingredient combo maintains DNA and targets senescence

NOVOS, a company that develops science-based products to slow down aging, has announced the results of two studies demonstrating that the combination of ingredients in its products, NOVOS Core and NOVOS Boost, protect against DNA damage and cellular aging (senescence).

Protecting DNA

A study found that a combination of the 12 ingredients in NOVOS Core and the nicotinamide mononucleotide (NMN) in NOVOS Boost significantly protects cells against DNA damage over a wide dose range.

The study was done by Ichor Life Sciences, an independent third-party US-based lab specialised in DNA damage, cellular senescence and aging.

In the study, HUVEC cells (human umbilical vein endothelial cells) were treated with the
13-ingredient NOVOS formulation and then irradiated. Irradiation typically causes pronounced DNA damage. However, the cells exposed to NOVOS before irradiation had significantly less DNA damage after being exposed to radiation, as measured via 8-hydroxy-2′-deoxyguanosine (8-OHdG or 8-oxodG) levels. 8-OHdG is a measure of oxidative DNA damage. When DNA gets damaged, 8-OHdG is formed.

Treating cells with NOVOS was able to reduce DNA damage as measured by 8-OHdG by up to 77% and on average 68% compared to controls (figure 1).

Treating cells with NOVOS was able to reduce DNA damage as measured by 8-OHdG by up to 77% and on average 68% compared to controls
Irradiated cells treated with the NOVOS formulation (orange bars; different concentrations of NOVOS ranging from 50.0uM to 0.2 uM) showed significantly less DNA damage (as measured by 8-OHdG levels; the lower the bars, the less DNA damage) versus irradiated cells that weren’t treated with the NOVOS formulation (green & brown bars).

Researchers demonstrated that the NOVOS formulation protects against DNA damage over a wide range of doses, an effect mediated by DNA protective effects of multiple NOVOS ingredients at different doses and synergy between ingredients.

Empowered against senescence

Another study was conducted at the Ageing Research Laboratories at Newcastle University in the UK, an institution specialised in cellular senescence and aging. The study, which was was completed under the guidance of Dr Thomas von Zglinicki, Professor for Cell Gerontology at Newcastle University, found that the combination of multiple NOVOS ingredients could help the body better deal with senescent cells.

Senescent cells occur during aging and play an important role in the aging process. These cells accumulate various forms of damage, including DNA and epigenetic damage, and secrete substances that harm healthy surrounding cells.

Research has shown that countering senescent cells using senostatic drugs (which suppress senescent cells) can support the body to deal better with aging. In the UK study, researchers using cell size as marker for the senescent phenotype found that specific NOVOS ingredients had a senostatic effect, while not impacting normal, non-senescent cells.

A senostatic effect comprising a reduction in senescent cell size has also been observed with rapamycin, a prescription drug associated with increased longevity in multiple animal models.

Normal non-senescent cells were not impacted by the NOVOS formulation, demonstrating that specific NOVOS ingredients used in a synergistic combination can impact senescent cells while not impacting healthy cells — a common pitfall of “senolytic” molecules which seek to destroy senescent cells.

“As a data-centric, science-driven company, these early results are a great step forward for NOVOS, further contributing to the validation of our formulations that improve human longevity by targeting the biological causes of aging,” said Chris Mirabile, founder and CEO of NOVOS.

“We look forward to seeing results from additional studies in our pursuit of effective longevity formulations validated by science...We explained to the researchers that NOVOS has a synergistic approach,” says Mirabile. “NOVOS has multiple ingredients, and we believe that their synergy has a better impact than the ingredients do on their own – synergies can be incredibly powerful for longevity purposes. When the research team expressed their surprise at the findings, this was a good sign that the results were beyond ordinary.”

Experimenting on human cells with a range of different concentrations of NOVOS Core and NOVOS Boost formula, the researchers discovered that damage to DNA from irradiation was reduced by up to a whopping 77% and on average by 68%.

The other study, also on human cells, was carried out by Professor von Zglinicki at the University of Newcastle, a renowned expert on senescence and how it relates to mammalian aging.

Von Zglinicki’s research discovered that the NOVOS formula was able to reduce the size of senescent cells by, on average, 40%.

“Essentially, it was a senostatic effect,” explains Mirabile. “This means that senescent cells can be made less ‘senescent-like’, helping the body to better deal with senescent cells during aging – and in our estimation, this is a fantastic result.”

Senolytics, which eliminate senescent cells by rendering them vulnerable to apoptosis – natural, programmed cell death – come with downsides. Not only can there be unpleasant side effects, but the remains need to be recognised and cleared away by the immune system to prevent secondary necrosis.

Senostatic approaches, on the other hand, do not destroy the cell; instead, they suppress the toxic senescence-associated secretory phenotype, SASP.

“In our opinion, the senostatic approach is possibly the best approach at this point in time,” Mirabile says. “We don’t fully understand senescent cells, and as Dr Judith Campisi has shown, getting rid of all them can be dangerous – some of them serve a function. But, if we can prevent them from proliferating, reduce their size and thereby reduce the degree to which they have a negative effect, then that is a safer approach.”

Mirabile makes the point that rapamycin has been shown to have a senostatic effect, but is a much more aggressive drug than people are willing to take – safety is key to NOVOS’ philosophy.

“People are experimenting with the senolytic dasatinib + quercetin, but we ultimately decided against quercetin as an ingredient because it can have negative effects on healthy cells, particularly in high doses, for example, on stem cells,” he says. “We don’t want to cause harm to healthy cells, we only want to address the senescent cells. A senostatic approach balances the cost benefits of coping with senescent cells.”

Many of NOVOS’ ingredients act on multiple aging mechanisms, with a synergistic MOA being what the company feels is its USP.

“We try to address all ten hallmarks of aging with our formulations,” explains Mirabile referring to recent thinking that has added crosslinking to the original nine hallmarks.

“Crosslinking can cause aging, so we’ve included that in the mechanisms of aging we address. DNA damage is a driver of aging and it can drive senescence, in and of itself.”

These are two particularly powerful aging mechanisms, as is epigenetics, but while the company hasn’t yet completed any studies of NOVOS’ effects on the epigenome, it already includes several ingredients that have already been proven to have favourable effects on the epigenome, such as microdosed lithium, calcium alpha ketoglutarate and glycine.

“There’s no reason for us to expect that we won’t have a favourable impact on such a powerful mechanism as epigenetics,” says Mirabile. “We’ve always been very confident that our formulation had an impact on all the mechanisms of aging – we compiled a page with references to hundreds of scientific studies for each of our ingredients – now it’s a matter of further proving that out, and so we are going to let science answer for us. I believe that in these studies, we have the two first proof points that two of the more powerful mechanisms of aging are addressed by NOVOS – and in humans [1].”

The NOVOS formulation acts to prevent DNA damage – an ounce of prevention is worth a pound of cure, quotes Mirabile, but he explains that it also helps the body cope with any damage and to repair it.

“NOVOS contains fisetin, pterostilbene and ginger that can activate SIRT damage repair genes [2,3,4], as well as glucosamine, which can effect DNA demethylation, lithium, which has various epigenetic effects that are not sirtuin-mediated and glycine, which can impact the epigenome of the mitochondrial DNA,” Mirabile says.

Education about longevity is something that Mirabile and NOVOS take a keen interest in.

People that understand longevity and the mechanisms of aging are very aware of senescence, says Mirabile, but not so much in the wider world. “There is a need to educate people, to make them aware that there are reasons we get older, there are reasons we malfunction and there are reasons we get chronic illness,” he says. “We don’t necessarily know all the answers, but to be proactive with the knowledge we do have is vital. When it comes to reducing disease, extending lifespan and making people healthier for longer, we don’t have decades to wait – that’s the logic behind our synergistic approach.”

From a scientific perspective, these are just the first steps NOVOS is taking. The company is continuing to investigate the power and properties of the NOVOS formulations and has also filed patents in addition to NOVOS Core, which is patent pending.

“We have visions for additional products that will also take a very unique approach to address aging,” says Mirabile. “We hope to continue to demonstrate we’re ahead of the curve when it comes to longevity.”

References:

[1] https://novoslabs.com/the-science-behind-novos-anti-aging-supplement/ 
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621366/
[3] https://www.frontiersin.org/articles/10.3389/fphar.2021.785403/full
[4] https://pubmed.ncbi.nlm.nih.gov/35257553/

Comments

Archive

Show more

Popular posts from this blog

How to Detox Spike Protein After COVID - Dr Mercola

FLCCC I-MASK+ Protocol for COVID-19 (2023)

Lumbrokinase vs Nattokinase vs Serrapeptase: What's the Difference?

12 Types of Zinc Supplementation and Absorption 2023

How to Get Ivermectin in the US: Pharmacies (2023)

Fenbendazole for Cancer: 2023 Review

Zelenko Protocols: COVID-19 Prophylaxis and Treatment

How Linoleic Acid Wrecks Your Health (2023) - Dr Mercola

Updates on the GMO Mosquito Release (2023)

NAC vs NAD vs NR vs NMN? What are the Differences?